Infinity Bio is a company headquartered in the United States.
Infinity Bio develops and provides advanced antibody reactome profiling technology, enabling researchers to decode antibody interactions with comprehensive antigen libraries for applications in immunology research and diagnostics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.